Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,068,950 | 3,834,204 | 3,659,374 | 3,094,238 | 2,363,567 |
| Cost of Goods | 445,713 | 435,577 | 540,517 | 440,760 | 148,917 |
| Gross Profit | 3,623,237 | 3,398,627 | 3,118,857 | 2,653,478 | 2,214,650 |
| Operating Expenses | 2,907,320 | 2,820,624 | 3,184,902 | 2,483,960 | 1,837,494 |
| Operating Income | 716,630 | 578,580 | -65,528 | 170,278 | 378,073 |
| Interest Expense | 238,097 | 289,438 | 288,242 | 278,766 | 99,707 |
| Other Income | -9,842 | 5,778 | -28,935 | -5,064 | -6,233 |
| Pre-tax Income | 468,691 | 294,920 | -382,705 | -113,552 | 272,133 |
| Income Tax | -91,429 | -119,912 | -158,645 | 216,116 | 33,517 |
| Net Income Continuous | 560,120 | 414,832 | -224,060 | -329,668 | 238,616 |
| Net Income | $560,120 | $414,832 | $-224,060 | $-329,668 | $238,616 |
| EPS Basic Total Ops | 9.06 | 6.55 | -3.58 | -5.52 | 4.28 |
| EPS Basic Continuous Ops | 9.06 | 6.55 | -3.58 | -5.52 | 4.28 |
| EPS Diluted Total Ops | 8.65 | 6.10 | -3.58 | -5.52 | 4.22 |
| EPS Diluted Continuous Ops | 8.49 | 5.76 | -3.58 | -5.52 | 4.22 |
| EPS Diluted Before Non-Recurring Items | 17.95 | 15.76 | 10.75 | 14.18 | 10.77 |
| EBITDA(a) | $1,376,697 | $1,217,276 | $563,943 | $722,761 | $656,326 |